Previous 10 | Next 10 |
OraSure Technologies (OSUR): Q3 GAAP EPS of $0.01 beats by $0.08.Revenue of $48M (+33.4% Y/Y) beats by $8.8M.Q4 guidance: Net revenues of $55M-$60M vs consensus of $55.6M.Shares -5.3%.Press Release For further details see: OraSure Technologies EPS beats by $0.08, beats on revenue, Q4 re...
Net T hird Q uarter R evenues of $ 48.0 M illion Increased 33 % Year-Over-Year, D riven by $ 18 . 4 M illion in S ales of O ral F luid C ollection D evices for COVID...
OraSure Technologies (NASDAQ:OSUR) is scheduled to announce Q3 earnings results on Wednesday, November 4th, after market close.The consensus EPS Estimate is -$0.06 (-128.6% Y/Y) and the consensus Revenue Estimate is $39.2M (+8.9% Y/Y).Over the last 1 year, OSUR has beaten EPS estimates 100% o...
The FDA grants emergency use authorization ((EUA)) to OraSure Technologies (OSUR) unit DNA Genotek's ORAcollect-RNA saliva collection device for the collection, stabilization and transport of saliva specimens suspected of containing SARS-CoV-2 RNA, the second FDA EUA nod for its saliva collec...
BETHLEHEM, Pa., Nov. 03, 2020 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, today announced its DNA Genotek subsidiary has received Emergency Use Auth...
OraSure receives emergency use authorization for OMNIgene. Keros Therapeutics initiates Phase 2 clinical trial for Myelodysplastic Syndromes. Affimed to collaborate with NKMax America for SNK01 natural killer cell therapy. For further details see: OraSure's Emergency Use...
BETHLEHEM, Pa., Oct. 21, 2020 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering 2020 third quarter financial results and certain business developments for 5:00 pm ET (2:00 pm PT) on Wednesday, Novemb...
Shares of OraSure Technologies (NASDAQ: OSUR) were soaring 15.2% as of 11:09 a.m. EDT on Monday. The big jump came after the company announced that the Food and Drug Administration granted Emergency Use Authorization (EUA) for the OMNIgene ORAL saliva collection and stabilization de...
Gainers: BOQI International Medical (BIMI) +70%, BioSpecifics Technologies (BSTC) +44%, Liquidia Technologies (LQDA) +19%, OraSure Technologies (OSUR) +17%, Centogene (CNTG) +17%.Losers: Aerie Pharmaceuticals (AERI) -14%, ReWalk Robo...
Kaixin Auto Holdings (KXIN) +57%.Midatech Pharma plc (MTP) +42% after announcing positive results from a Phase I study evaluating MTX110.Front Yard Residential (RESI) +34% after announcing going private deal valued at ~$2.4B.ARC Document Solutions (ARC) +26% on prelim...
News, Short Squeeze, Breakout and More Instantly...
OraSure Technologies Inc. Company Name:
OSUR Stock Symbol:
NASDAQ Market:
OraSure Technologies Inc. Website:
2024-07-02 09:00:08 ET Vijay Kumar from Evercore ISI issued a price target of $4.50 for OSUR on 2024-07-02 08:07:00. The adjusted price target was set to $4.50. At the time of the announcement, OSUR was trading at $4.27. OSUR currently trades -49.59% versus its 52 week h...
BETHLEHEM, Pa., June 27, 2024 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care and home diagnostic tests and sample management solutions today announced its support of HIV testing initiatives taking place across the nation in recognition of National HIV Tes...
KKR, CrowdStrike Holdings and GoDaddy Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600 KKR, CrowdStrike Holdings and GoDaddy Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600 PR Newswire NEW YORK , ...